Systemic juvenile idiopathic arthritis and adult-onset Still’s disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still’s diseaseArianna De Matteis, Sara Bindoli, Fabrizio De Benedetti, Loreto Carmona, Bruno Fautrel, Stéphane Mitrovic
24 September 2024
Plasma proteome profiling in giant cell arteritisKevin Y Cunningham, Benjamin Hur, Vinod K Gupta, Matthew J Koster, Cornelia M Weyand, David Cuthbertson, Nader A Khalidi, Curry L Koening, Carol A Langford, Carol A McAlear, Paul A Monach, Larry W Moreland, Christian Pagnoux, Rennie L Rhee, Philip SeoSee the full list of authors
17 August 2024
Positive feedback loop PU.1-IL9 in Th9 promotes rheumatoid arthritis developmentJiajie Tu, Weile Chen, Wei Huang, Xinming Wang, Yilong Fang, Xuming Wu, Huiru Zhang, Chong Liu, Xuewen Tan, Xiangling Zhu, Huihui Wang, Dafei Han, Yizhao Chen, Anqi Wang, Yuanyuan ZhouSee the full list of authors
20 August 2024
Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritisKaterina Kachler, Darja Andreev, Shreeya Thapa, Dmytro Royzman, Andreas Gießl, Shobika Karuppusamy, Mireia Llerins Perez, Mengdan Liu, Jörg Hofmann, Arne Gessner, Xianyi Meng, Simon Rauber, Alexander Steinkasserer, Martin Fromm, Georg SchettSee the full list of authors
4 July 2024
Helicobacter pylori upregulates PAD4 expression via stabilising HIF-1α to exacerbate rheumatoid arthritisHui Wu, Hanmei Yuan, Jin Zhang, Taojun He, Yilin Deng, Ying Chen, Yunqi Zhang, Weisan Chen, Chao Wu
6 August 2024
Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathwaysGeorgia-Savina Moysidou, Panagiotis Garantziotis, George Sentis, Dimitra Nikoleri, Nikolaos Malissovas, Myrto Nikoloudaki, Eirini-Maria Stergioti, Styliani Polia, Nikolaos Paschalidis, Anastasia Filia, Maria Grigoriou, Dionysis Nikolopoulos, Noemin Kapsala, Spyridon Katechis, Antonis FanouriakisSee the full list of authors
7 November 2024
Cure as a treatment target in rheumatoid arthritis and systemic sclerosis—achievable aim or mission impossible? FOREUM stimulates new industry-academia collaborationKenneth Frank Baker, Julia Spierings, Martin Brom, Timothy Radstake, Emma Smith, Roberta Weiss, Gerd R Burmester, , FOREUM Boot Camp Working Group member, Johannes WJ Bijlsma, Iain McInnes, Kenneth Baker, Rik Lories, Costantino Pitzalis, Jörg HW DistlerSee the full list of authors
12 November 2024
EULAR points to consider for patient education in physical activity and self-management of pain during transitional careJavier Courel-Ibáñez, Rafael Prieto-Moreno, Erica Briones-Vozmediano, Patrocinio Ariza-Vega, Saskya Angevare, Jordi Anton, Ilaria Bini, Daniel Clemente, Matilde Correia, Wendy Costello, Diederik De Cock, Andrea Domján, Leticia Leon, Andréa Marques, Kirsten MindenSee the full list of authors
11 November 2024
Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological studyJohannes Iuel Berg, Sabrina Mai Nielsen, Esben Malm, John P A Ioannidis, Daniel E Furst, Josef S Smolen, Peter C Taylor, Lars Erik Kristensen, Simon Tarp, Torkell Ellingsen, Robin Christensen
8 November 2024
Dynamics of the gut microbiome in individuals at risk of rheumatoid arthritis: a cross-sectional and longitudinal observational studyChristopher M Rooney, Ian B Jeffery, Kulveer Mankia, Mark H Wilcox, Paul Emery
8 November 2024